Le Lézard
Classified in: Covid-19 virus
Subjects: HSP, STP, AVO

Los Angeles Says: Too Much Alcohol on These Streets!


LOS ANGELES, July 7, 2021 /PRNewswire/ -- Members of California Alcohol Policy Alliance (CAPA) will hold an opposition rally at the Los Angeles district office of California State Assemblymember Jesse Gabriel (D-Encino), principal author of  AB 61 & coauthor SB 314. Both bills focus on expanding alcohol consumption on public property.

As all California communities struggle to recover from COVID, those most disproportionately socio-economically impacted are black, brown and low-income. For them there is no relief in Gabriel's bills which prioritize business economic recovery. He is completely disregarding the unintended consequences of his misguided efforts: high costs of implementation, lack of infrastructure, and loss of overriding local control of cities to implement safe street and sidewalk initiatives for residents and business alike.

This is a social justice issue for low-income and communities of color, pedestrians and drivers already severely compromised by heavy policing, lack of resources, and limited access to walkable and family friendly city streets. Promoting the need for non-union low paying jobs for communities of color as a means to justify alcohol deregulation co-opts social justice and equity to advance corporate profits. The real question is: who is funding these initiatives because it is not the labor unions and it is not the community.

In 2020, Assemblymember Gabriel received $5,700 from the Beer, Wine and Liquor sector ? $4,700 from Anheuser-Busch (a multinational corporation headquartered in Belgium) and $1,000 from Wine Institute a corporate alcohol funded lobbyist organization. Gabriel's bills will effectively privatize public spaces and compromise pedestrian right-of-way safety in the City of Los Angeles.

What:   Opposition Rally & Call to Action
When:  Thursday July 8, 2020, 11 a.m. to noon
Where: 20750 Ventura Blvd. Suite 101, Woodland Hills, CA 91364
Who:

Why:   

With this event, CAPA is launching a public CALL to ACTION to demand that Assemblymember Gabriel, the Legislature, and the Governor acknowledge that excessive alcohol use is No. 3 on the list of preventable causes of death in California and stop any bills seeking to extend or expand COVID-19 regulatory rollbacks for economic relief.

Take Action here: : https://bit.ly/3oFz1uo or text PUBLICHEALTH to 313131 to tell legislators and the Governor to choose PUBLIC HEALTH over industry profits and STOP AB 61 AND SB 314.

The California Alcohol Policy Alliance (CAPA) unites diverse organizations and communities in California to protect health and safety, and prevent alcohol-related harm through statewide action.

CAPA Member Organizations

For more information go to: https://alcoholpolicyalliance.org/ or https://alcoholjustice.org/

CONTACT:

Mayra Jimenez 323 683-4687 


Raul Verdugo 310 689-9401


Michael Scippa 415 548-0492

 

SOURCE California Alcohol Policy Alliance


These press releases may also interest you

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

17 mai 2024
Federal, provincial and territorial (FPT) ministers responsible for culture and heritage held their annual meeting in Whitehorse, Yukon, on May 15?17, 2024, to discuss priority topics, share information and exchange best practices on current issues...

17 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

17 mai 2024
The TCW Group, a leading global asset management firm, today announced that, effective May 30, 2024, the listing exchange for shares of each of the following series (each, an "ETF" and, collectively, the "ETFs") of TCW ETF Trust (the "Trust") will be...

17 mai 2024
BioLineRx Ltd. ("BioLineRx" or the "Company"), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has received a notification letter from the Nasdaq Stock Market LLC...

17 mai 2024
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a private placement transaction (the...



News published on and distributed by: